Journal of Medical Case Reports (Apr 2021)

Resolution of enuresis with aripiprazole in children with psychiatric disorders: two case reports

  • Rosaria Nardello,
  • Fulvio Guccione,
  • Claudia Gliubizzi,
  • Antonio Marino,
  • Mariarita Capizzi,
  • Salvatore Mangano

DOI
https://doi.org/10.1186/s13256-021-02691-y
Journal volume & issue
Vol. 15, no. 1
pp. 1 – 3

Abstract

Read online

Abstract Background Aripiprazole is a third-generation atypical antipsychotic drug that acts as a stabilizer of the dopaminergic and serotonergic system. As partial agonist of the dopamine (D2) and serotonin (5-HT1A) receptors, it appears to be effective in reducing mania in patients with bipolar disorder, tics in Tourette Syndrome, aggression in schizophrenia and autism spectrum disorder. Enuresis has been reported among its side effects. Only a few studies, with conflicting results, have investigated the relationship between aripiprazole and enuresis. Case presentation We report the disappearance of enuresis in a Caucasian girl with intellectual disability and oppositional defiant disorder and in a Caucasian boy with intellectual disability and early-onset psychosis, both following initiation of treatment with aripiprazole. Conclusion The aim of this study was to contribute to the literature on the use of aripripazole in subjects with enuresis. Our findings lead us to suggest that aripiprazole is less burdened with side effects, including bedwetting, than other antipsychotic drugs.

Keywords